This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_LARYNX_EXALLC for full statistics.
Malignant neoplasm of larynx
DOID EFO MESH SNOMED Endpoint Browser
C3_LARYNX
laryngeal neoplasm: A benign or malignant neoplasm involving the larynx.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C32
Cause of death: ICD-9
161
Cause of death: ICD-8
161
Cancer registry: Topography ICD-O-3
C32
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
466
Check minimum number of events None
466
Include endpoints None
466
Remove individuals based on genotype QC
451
C3_LARYNX
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of larynx
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of larynx (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck (controls excluding all cancers)
- Malignant neoplasm of respiratory system and intrathoracic organs (controls excluding all cancers)
- Malignant neoplasm of respiratory system and intrathoracic organs
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 451 | 54 | 397 |
| Unadjusted prevalence (%) | 0.11 | 0.02 | 0.22 |
| Mean age at first event (years) | 66.21 | 61.86 | 66.80 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_LARYNX – Malignant neoplasm of larynx
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of larynx
↥Endpoint not on priority list, no data to show.